Treatment of Acyclovir-Resistant Herpes Simplex Virus with Continuous Infusion of High-Dose Acyclovir in Hematopoietic Cell Transplant Patients

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 2, 2011, Pages 259-264

  Kim, Janet H ^a   Schaenman, Joanna M ^a   Ho, Dora Y ^a   Brown, Janice M Y ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acyclovir; Drug resistance; Hematopoietic stem cell transplantation; Immunocompromised host

Indexed keywords

ACICLOVIR; CIDOFOVIR; CORTICOSTEROID; CYCLOSPORIN; FAMCICLOVIR; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DRUG DOSE REGIMEN; DRUG MEGADOSE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; LOW DRUG DOSE;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; DRUG RESISTANCE, MULTIPLE, VIRAL; DRUG RESISTANCE, VIRAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HUMANS; IMMUNOCOMPROMISED HOST; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; SIMPLEXVIRUS; TREATMENT OUTCOME;

EID: 79151476734     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.06.020     Document Type: Article

References (16)

1. Yahav D., Gafter-Gvili A., Muchtar E., et al. Antiviral prophylaxis in haematological patients: systematic review and meta-analysis. Eur J Cancer 2009, 45:3131-3148.
2. Wood M.J. Viral infections in neutropenia-current problems and chemotherapeutic control. J Antimicrob Chemother 1998, 41(Suppl D):81-93.
3. Sable C.A., Donowitz G.R. Infections in bone marrow transplant recipients. Clin Infect Dis 1994, 18:273-281. quiz 282-274.
4. Bacon T.H., Levin M.J., Leary J.J., Sarisky R.T., Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev 2003, 16:114-128.
5. Morfin F., Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol 2003, 26:29-37.
6. Chen Y., Scieux C., Garrait V., et al. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin Infect Dis 2000, 31:927-935.
7. Tomblyn M., Chiller T., Einsele H., et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009, 15:1143-1238.
8. Darville J.M., Ley B.E., Roome A.P., Foot A.B. Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population. Bone Marrow Transplant 1998, 22:587-589.
9. Chakrabarti S., Pillay D., Ratcliffe D., Cane P.A., Collingham K.E., Milligan D.W. Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance. J Infect Dis 2000, 181:2055-2058.
10. Danve-Szatanek C., Aymard M., Thouvenot D., et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol 2004, 42:242-249.
11. Erard V., Wald A., Corey L., Leisenring W.M., Boeckh M. Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease. J Infect. Dis 2007, 196:266-270.
12. Eisen D., Essell J., Broun E.R., Sigmund D., DeVoe M. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy. Bone Marrow Transplant 2003, 31:51-55.
13. Fletcher C.V., Englund J.A., Bean B., Chinnock B., Brundage D.M., Balfour H.H. Continuous infusion of high-dose acyclovir for serious herpesvirus infections. Antimicrob Agents Chemother 1989, 33:1375-1378.
14. Engel J.P., Englund J.A., Fletcher C.V., Hill E.L. Treatment of resistant herpes simplex virus with continuous-infusion acyclovir. JAMA 1990, 263:1662-1664.
15. Bean B., Fletcher C., Englund J., Lehrman S.N., Ellis M.N. Progressive mucocutaneous herpes simplex infection because of acyclovir-resistant virus in an immunocompromised patient: correlation of viral susceptibilities and plasma levels with response to therapy. Diagn Microbiol Infect Dis 1987, 7:199-204.
16. Laskin O.L. Acyclovir. Pharmacology and clinical experience. Arch Intern Med 1984, 144:1241-1246.